Conditions: COPD
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 138
Healthy volunteers: no

Brief summary:
This is an open-label, multi-center study to evaluate the accuracy, reliability and functionality of the Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) dose indicator in adult subjects with moderate to very severe COPD over a 4-week Treatment Period.

Detailed description:

Arms:
arm 1: Glycopyrronium and Formoterol Fumarate Metered-dose Inhaler (GFF MDI), PT003

Interventions: intervention 1: Glycopyrronium and Formoterol Fumarate Metered-dose Inhaler
Intervention descriptions: intervention 1: GFF MDI administered as 2 inhalations BID

Protocol document: